Cinacalcet Hydrochloride is a calcimimetic agent that allosterically sensitises the calcium-sensing receptor on parathyroid cells, lowering PTH secretion, used for secondary hyperparathyroidism in dialysis patients and primary hyperparathyroidism. Simson Pharma's Cinacalcet Hydrochloride reference standard and impurities support stability-indicating method development for this renal-disease focused therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cinacalcet Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.